SOAM
ABVX

SBI Okasan Asset Management’s Abivax ABVX Stock Holding History

SBI Okasan Asset Management’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$625K Hold
6,500
– – 0.02% 194
2026
Q1 		$660K Buy
+6,500
New +$769K 0.03% 163

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SBI Okasan Asset Management's ABVX Position: Q2 2026 in Review

SBI Okasan Asset Management held its Abivax (ABVX) position steady in Q2 2026 at 6,500 shares worth $625K. The position accounts for 0.02% of the portfolio, ranked #194.

SBI Okasan Asset Management first reported a position in ABVX in Q1 2026 and has held it in 2 quarters since. The position peaked at $660K in Q1 2026. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • SBI Okasan Asset Management held 6,500 shares of Abivax worth $625K as of Q2 2026.
  • SBI Okasan Asset Management left its Abivax share count unchanged in Q2 2026.
  • Abivax made up 0.02% of SBI Okasan Asset Management's portfolio in Q2 2026, its #194 holding.
  • SBI Okasan Asset Management first reported a position in Abivax in Q1 2026 and has held it in 2 quarters since.
  • SBI Okasan Asset Management's Abivax position peaked at $660K in Q1 2026.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on SBI Okasan Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.